|
1
|
Gendler SJ and Spicer AP: Epithelial mucin
genes. Annu Rev Physiol. 57:607–634. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hollingsworth MA and Swanson BJ: Mucins in
cancer: Protection and control of the cell surface. Nat Rev Cancer.
4:45–60. 2004. View Article : Google Scholar
|
|
3
|
Demouveaux B, Gouyer V, Gottrand F, Narita
T and Desseyn JL: Gel-forming mucin interactome drives mucus
viscoelasticity. Adv Colloid Interface Sci. 252:69–82. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kohout VR, Wardzala CL and Kramer JR:
mirror image mucins and thio mucins with tunable biodegradation. J
Am Chem Soc. 145:16573–16583. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arai J, Hayakawa Y, Tateno H, Murakami K,
Hayashi T, Hata M, Matsushita Y, Kinoshita H, Abe S, Kurokawa K, et
al: Impaired glycosylation of gastric mucins drives gastric
tumorigenesis and serves as a novel therapeutic target.
Gastroenterology. 167:505–521 e19. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Perez-Vilar J and Hill RL: The structure
and assembly of secreted mucins. J Biol Chem. 274:31751–31754.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Strous GJ and Dekker J: Mucin-type
glycoproteins. Crit Rev Biochem Mol Biol. 27:57–92. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Y, Zhao YH, Kalaslavadi TB, Hamati E,
Nehrke K, Le AD, Ann DK and Wu R: Genome-wide search and
identification of a novel gel-forming mucin MUC19/Muc19 in
glandular tissues. Am J Respir Cell Mol Biol. 30:155–165. 2004.
View Article : Google Scholar
|
|
9
|
Higuchi T, Orita T, Nakanishi S, Katsuya
K, Watanabe H, Yamasaki Y, Waga I, Nanayama T, Yamamoto Y, Munger
W, et al: Molecular cloning, genomic structure, and expression
analysis of MUC20, a novel mucin protein, up-regulated in injured
kidney. J Biol Chem. 279:1968–1979. 2004. View Article : Google Scholar
|
|
10
|
Marimuthu S, Rauth S, Ganguly K, Zhang C,
Lakshmanan I, Batra SK and Ponnusamy MP: Mucins reprogram stemness,
metabolism and promote chemoresistance during cancer progression.
Cancer Metastasis Rev. 40:575–588. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moniaux N, Escande F, Porchet N, Aubert JP
and Batra SK: Structural organization and classification of the
human mucin genes. Front Biosci. 6:D1192–D1206. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chaturvedi P, Singh AP and Batra SK:
Structure, evolution, and biology of the MUC4 mucin. FASEB J.
22:966–981. 2008. View Article : Google Scholar
|
|
13
|
Mukhopadhyay P, Chakraborty S, Ponnusamy
MP, Lakshmanan I, Jain M and Batra SK: Mucins in the pathogenesis
of breast cancer: Implications in diagnosis, prognosis and therapy.
Biochim Biophys Acta. 1815:224–240. 2011.PubMed/NCBI
|
|
14
|
Breugelmans T, Oosterlinck B, Arras W,
Ceuleers H, De Man J, Hold GL, De Winter BY and Smet A: The role of
mucins in gastrointestinal barrier function during health and
disease. Lancet Gastroenterol Hepatol. 7:455–471. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Devine PL and McKenzie IF: Mucins:
Structure, function, and associations with malignancy. Bioessays.
14:619–625. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gray T, Koo JS and Nettesheim P:
Regulation of mucous differentiation and mucin gene expression in
the tracheobronchial epithelium. Toxicology. 160:35–46. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marzio A, Kurz E, Sahni JM, Di Feo G,
Puccini J, Jiang S, Hirsch CA, Arbini AA, Wu WL, Pass HI, et al:
EMSY inhibits homologous recombination repair and the interferon
response, promoting lung cancer immune evasion. Cell.
185:169–183.e19. 2022. View Article : Google Scholar
|
|
18
|
Yang K, Wu J, Xu T, Zhou Y, Liu W and Yang
L: Machine learning to predict distant metastasis and prognostic
analysis of moderately differentiated gastric adenocarcinoma
patients: A novel focus on lymph node indicators. Front Immunol.
15:13986852024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Lu Q, Zhou H, Liu J, Nadorp B,
Lasry A, Sun Z, Lai B, Rona G, Zhang J, et al: A
membrane-associated MHC-I inhibitory axis for cancer immune
evasion. Cell. 186:3903–3920.e21. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reily C, Stewart TJ, Renfrow MB and Novak
J: Glycosylation in health and disease. Nat Rev Nephrol.
15:346–366. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen K, Gu Y, Cao Y, Fang H, Lv K, Liu X,
He X, Wang J, Lin C, Liu H, et al: TIM3(+) cells in gastric cancer:
Clinical correlates and association with immune context. Br J
Cancer. 126:100–108. 2022. View Article : Google Scholar
|
|
22
|
Lai Y, Huang C, Wu J, Yang K and Yang L:
Ferroptosis in cancer: A new perspective on T cells. Int
Immunopharmacol. 143(Pt 3): 1135392024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ratan C, Cicily K D D, Nair B and Nath LR:
MUC glycoproteins: Potential biomarkers and molecular targets for
cancer therapy. Curr Cancer Drug Targets. 21:132–152. 2021.
View Article : Google Scholar
|
|
24
|
Liu Y, Tang L, Gao N, Diao Y, Zhong J,
Deng Y, Wang Z, Jin G and Wang X: Synthetic MUC1 breast cancer
vaccine containing a Toll-like receptor 7 agonist exerts antitumor
effects. Oncol Lett. 20:2369–2377. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guillen-Poza PA, Sánchez-Fernández EM,
Artigas G, García Fernández JM, Hinou H, Ortiz Mellet C, Nishimura
SI and Garcia-Martin F: Amplified detection of breast cancer
autoantibodies using MUC1-based Tn antigen mimics. J Med Chem.
63:8524–8533. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xi X, Wang J, Qin Y, Huang W, You Y and
Zhan J: Glycosylated modification of MUC1 maybe a new target to
promote drug sensitivity and efficacy for breast cancer
chemotherapy. Cell Death Dis. 13:7082022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Yin L, Chen S, Li Z, Ding J, Wu J,
Yang K and Xu J: The perspectives of NETosis on the progression of
obesity and obesity-related diseases: mechanisms and applications.
Front Cell Dev Biol. 11:12213612023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim GE, Bae HI, Park HU, Kuan SF, Crawley
SC, Ho JJ and Kim YS: Aberrant expression of MUC5AC and MUC6
gastric mucins and sialyl Tn antigen in intraepithelial neoplasms
of the pancreas. Gastroenterology. 123:1052–1060. 2022. View Article : Google Scholar
|
|
29
|
Babu SD, Jayanthi V, Devaraj N, Reis CA
and Devaraj H: Expression profile of mucins (MUC2, MUC5AC and MUC6)
in Helicobacter pylori infected pre-neoplastic and neoplastic human
gastric epithelium. Mol Cancer. 5:102006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dwertmann Rico S, Schliesser SJA, Gorbokon
N, Dum D, Menz A, Buscheck F, Hinsch A, Lennartz M, von Bargen C,
Bawahab AA, et al: Pattern of MUC6 expression across 119 different
tumor types: A tissue microarray study on 15 412 tumors. Pathol
Int. 73:281–296. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bartman AE, Buisine MP, Aubert JP, Niehans
GA, Toribara NW, Kim YS, Kelly EJ, Crabtree JE and Ho SB: The MUC6
secretory mucin gene is expressed in a wide variety of epithelial
tissues. J Pathol. 186:398–405. 1998. View Article : Google Scholar
|
|
32
|
Fan H, Wu J, Yang K, Xiong C, Xiong S, Wu
X, Fang Z, Zhu J and Huang J: Dietary regulation of intestinal stem
cells in health and disease. Int J Food Sci Nutr. 74:730–745. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee HS, Lee HK, Kim HS, Yang HK, Kim YI
and Kim WH: MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric
carcinomas: Their roles as prognostic indicators. Cancer.
92:1427–1434. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Freire T, Lo-Man R, Piller F, Piller V,
Leclerc C and Bay S: Enzymatic large-scale synthesis of MUC6-Tn
glycoconjugates for antitumor vaccination. Glycobiology.
16:390–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Freire T, Lo-Man R, Bay S and Leclerc C:
Tn glycosylation of the MUC6 protein modulates its immunogenicity
and promotes the induction of Th17-biased T cell responses. J Biol
Chem. 286:7797–7811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Freire T, Bay S, von Mensdorff-Pouilly S
and Osinaga E: Molecular basis of incomplete O-glycan synthesis in
MCF-7 breast cancer cells: Putative role of MUC6 in Tn antigen
expression. Cancer Res. 65:7880–7887. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tavares C, de Oliveira JT, Lopes C,
Carvalheira J, Matos AJ, Rutteman G, Reis CA and Gärtner F: Mucin 6
and Tn antigen expression in canine mammary tumours: Correlation
with pathological features. J Comp Pathol. 147:410–418. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Plender EG, Prodanov T, Hsieh P, Nizamis
E, Harvey WT, Sulovari A, Munson KM, Kaufman EJ, O'Neal WK,
Valdmanis PN, et al: Structural and genetic diversity in the
secreted mucins MUC5AC and MUC5B. Am J Hum Genet. 111:1700–1716.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gendler SJ, Burchell JM, Duhig T, Lamport
D, White R, Parker M and Taylor-Papadimitriou J: Cloning of partial
cDNA encoding differentiation and tumor-associated mucin
glycoproteins expressed by human mammary epithelium. Proc Natl Acad
Sci USA. 84:6060–6064. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gum JR Jr, Hicks JW, Toribara NW, Rothe
EM, Lagace RE and Kim YS: The human MUC2 intestinal mucin has
cysteine-rich subdomains located both upstream and downstream of
its central repetitive region. J Biol Chem. 267:21375–21383. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Toribara NW, Roberton AM, Ho SB, Kuo WL,
Gum E, Hicks JW, Gum JR Jr, Byrd JC, Siddiki B and Kim YS: Human
gastric mucin. Identification of a unique species by expression
cloning. J Biol Chem. 268:5879–5885. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lang T: Tandem repeats structure of
gel-forming mucin domains could be revealed by SMRT sequencing
data. Sci Rep. 12:206522022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Karbhari DS, Panwalla NM, Mondkar AM and
Motashaw ND: Eclampsia-the influence of antenatal care. J Postgrad
Med. 18:175–180. 1972.PubMed/NCBI
|
|
44
|
Kornfeld R and Kornfeld S: Assembly of
asparagine-linked oligosaccharides. Annu Rev Biochem. 54:631–664.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schwarz F and Aebi M: Mechanisms and
principles of N-linked protein glycosylation. Curr Opin Struct
Biol. 21:576–582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ruddock LW and Molinari M: N-glycan
processing in ER quality control. J Cell Sci. 119(Pt 21):
4373–4380. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Stanley P: Golgi glycosylation. Cold
Spring Harb Perspect Biol. 3:a0051992011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Marth JD: Complexity in O-linked
oligosaccharide biosynthesis engendered by multiple polypeptide
N-acetylgalactosaminyltransferases. Glycobiology. 6:701–705. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rose MC and Voynow JA: Respiratory tract
mucin genes and mucin glycoproteins in health and disease. Physiol
Rev. 86:245–278. 2006. View Article : Google Scholar
|
|
50
|
Kasprzak A and Adamek A: Mucins: The old,
the new and the promising factors in hepatobiliary carcinogenesis.
Int J Mol Sci. 20:12882019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Van Acker SI, Van den Bogerd B, Van Acker
ZP, Vailionytė A, Haagdorens M, Koppen C, Ní Dhubhghaill S, Dartt
DA and Pintelon I: Characterisation of gel-forming mucins produced
in vivo and in ex vivo conjunctival explant cultures. Int J Mol
Sci. 22:105282021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Rousseau K, Byrne C, Kim YS, Gum JR,
Swallow DM and Toribara NW: The complete genomic organization of
the human MUC6 and MUC2 mucin genes. Genomics. 83:936–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Desseyn JL, Aubert JP, Porchet N and Laine
A: Evolution of the large secreted gel-forming mucins. Mol Biol
Evol. 17:1175–1184. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kwon JA, Lee SY, Ahn EK, Seol SY, Kim MC,
Kim SJ, Kim SI, Chu IS and Leem SH: Short rare MUC6
minisatellites-5 alleles influence susceptibility to gastric
carcinoma by regulating gene. Hum Mutat. 31:942–949. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Han HS, Lee SY, Lee KY, Hong SN, Kim JH,
Sung IK, Park HS, Jin CJ and Min YI: Unclassified mucin phenotype
of gastric adenocarcinoma exhibits the highest invasiveness. J
Gastroenterol Hepatol. 24:658–666. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Leir SH and Harris A: MUC6 mucin
expression inhibits tumor cell invasion. Exp Cell Res.
317:2408–2419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lidell ME, Johansson ME and Hansson GC: An
autocatalytic cleavage in the C terminus of the human MUC2 mucin
occurs at the low pH of the late secretory pathway. J Biol Chem.
278:13944–13951. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Velcich A, Yang W, Heyer J, Fragale A,
Nicholas C, Viani S, Kucherlapati R, Lipkin M, Yang K and
Augenlicht L: Colorectal cancer in mice genetically deficient in
the mucin Muc2. Science. 295:1726–1729. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Toribara NW, Ho SB, Gum E, Gum JR Jr, Lau
P and Kim YS: The carboxyl-terminal sequence of the human secretory
mucin, MUC6. Analysis Of the primary amino acid sequence. J Biol
Chem. 272:16398–16403. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cozzi PJ, Wang J, Delprado W, Perkins AC,
Allen BJ, Russell PJ and Li Y: MUC1, MUC2, MUC4, MUC5AC and MUC6
expression in the progression of prostate cancer. Clin Exp
Metastasis. 22:565–573. 2005. View Article : Google Scholar
|
|
61
|
Senapati S, Sharma P, Bafna S, Roy HK and
Batra SK: The MUC gene family: Their role in the diagnosis and
prognosis of gastric cancer. Histol Histopathol. 23:1541–1552.
2008.PubMed/NCBI
|
|
62
|
Boccellato F, Woelffling S,
Imai-Matsushima A, Sanchez G, Goosmann C, Schmid M, Berger H, Morey
P, Denecke C, Ordemann J and Meyer TF: Polarised epithelial
monolayers of the gastric mucosa reveal insights into mucosal
homeostasis and defence against infection. Gut. 68:400–413. 2019.
View Article : Google Scholar
|
|
63
|
Yuki A, Fujii C, Yamanoi K, Matoba H,
Harumiya S, Kawakubo M and Nakayama J: Glycosylation of MUC6 by
α1,4-linked N-acetylglucosamine enhances suppression of pancreatic
cancer malignancy. Cancer Sci. 113:576–586. 2022. View Article : Google Scholar
|
|
64
|
Nagata K, Horinouchi M, Saitou M, Higashi
M, Nomoto M, Goto M and Yonezawa S: Mucin expression profile in
pancreatic cancer and the precursor lesions. J Hepatobiliary
Pancreat Surg. 14:243–254. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Prasad NB, Biankin AV, Fukushima N, Maitra
A, Dhara S, Elkahloun AG, Hruban RH, Goggins M and Leach SD: Gene
expression profiles in pancreatic intraepithelial neoplasia reflect
the effects of Hedgehog signaling on pancreatic ductal epithelial
cells. Cancer Res. 65:1619–1626. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Matsukita S, Nomoto M, Kitajima S, Tanaka
S, Goto M, Irimura T, Kim YS, Sato E and Yonezawa S: Expression of
mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the
breast: Comparison with invasive ductal carcinoma. Histopathology.
42:26–36. 2003. View Article : Google Scholar
|
|
67
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI
|
|
68
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
69
|
Ding JT, Yang KP, Zhou HN, Huang YF, Li H
and Zong Z: Landscapes and mechanisms of CD8(+) T cell exhaustion
in gastrointestinal cancer. Front Immunol. 14:11496222023.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Li Z, Qi H, Li Z, Bao Y, Yang K and Min Q:
Research progress on the premature ovarian failure caused by
cisplatin therapy. Front Oncol. 13:12763102023. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Schistosomes, liver flukes and
Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 61:1–241.
1994.PubMed/NCBI
|
|
72
|
Nguyen TV, Janssen M Jr, Gritters P, te
Morsche RH, Drenth JP, van Asten H, Laheij RJ and Jansen JB: Short
mucin 6 alleles are associated with H pylori infection. World J
Gastroenterol. 12:6021–6025. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Kawakubo M, Ito Y, Okimura Y, Kobayashi M,
Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T and Nakayama
J: Natural antibiotic function of a human gastric mucin against
Helicobacter pylori infection. Science. 305:1003–1006. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Byrd JC, Yan P, Sternberg L, Yunker CK,
Scheiman JM and Bresalier RS: Aberrant expression of gland-type
gastric mucin in the surface epithelium of Helicobacter
pylori-infected patients. Gastroenterology. 113:455–464. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Van den Brink GR, Tytgat KM, Van der Hulst
RW, Van der Loos CM, Einerhand AW, Buller HA and Dekker J: H pylori
colocalises with MUC5AC in the human stomach. Gut. 46:601–607.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Jia Y, Persson C, Hou L, Zheng Z, Yeager
M, Lissowska J, Chanock SJ, Chow WH and Ye W: A comprehensive
analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes
and risk of stomach cancer. Cancer Causes Control. 21:313–321.
2010.
|
|
77
|
Khattab AZ, Nasif WA and Lotfy M: MUC2 and
MUC6 apomucins expression in human gastric neoplasm: An
immunohistochemical analysis. Med Oncol. 28(Suppl 1): S207–S213.
2011. View Article : Google Scholar
|
|
78
|
Marin F, Bonet C, Munoz X, Garcia N, Pardo
ML, Ruiz-Liso JM, Alonso P, Capellà G, Sanz-Anquela JM, González CA
and Sala N: Genetic variation in MUC1, MUC2 and MUC6 genes and
evolution of gastric cancer precursor lesions in a long-term
follow-up in a high-risk area in Spain. Carcinogenesis.
33:1072–1080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Pinto-de-Sousa J, David L, Reis CA, Gomes
R, Silva L and Pimenta A: Mucins MUC1, MUC2, MUC5AC and MUC6
expression in the evaluation of differentiation and
clinico-biological behaviour of gastric carcinoma. Virchows Arch.
440:304–310. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Pinto-de-Sousa J, Reis CA, David L,
Pimenta A and Cardoso-de-Oliveira M: MUC5B expression in gastric
carcinoma: Relationship with clinico-pathological parameters and
with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Virchows
Arch. 444:224–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Reis CA, David L, Carvalho F, Mandel U, de
Bolos C, Mirgorodskaya E, Clausen H and Sobrinho-Simões M:
Immunohistochemical study of the expression of MUC6 mucin and
co-expression of other secreted mucins (MUC5AC and MUC2) in human
gastric carcinomas. J Histochem Cytochem. 48:377–388. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Shiroshita H, Watanabe H, Ajioka Y,
Watanabe G, Nishikura K and Kitano S: Re-evaluation of mucin
phenotypes of gastric minute well-differentiated-type
adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2
and CD10 stains. Pathol Int. 54:311–321. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Barua RR, Uozaki H, Chong JM, Ushiku T,
Hino R, Chang MS, Nagai H and Fukayama M: Phenotype analysis by
MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr
virus-associated gastric carcinoma. J Gastroenterol. 41:733–739.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Tjandra D, Busuttil RA and Boussioutas A:
Gastric intestinal metaplasia: Challenges and the opportunity for
precision prevention. Cancers (Basel). 15:39132023. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zheng H, Takahashi H, Nakajima T, Murai Y,
Cui Z, Nomoto K, Tsuneyama K and Takano Y: MUC6 down-regulation
correlates with gastric carcinoma progression and a poor prognosis:
An immunohistochemical study with tissue microarrays. J Cancer Res
Clin Oncol. 132:817–823. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Oosterlinck B, Ceuleers H, Arras W, De Man
JG, Geboes K, De Schepper H, Peeters M, Lebeer S, Skieceviciene J,
Hold GL, et al: Mucin-microbiome signatures shape the tumor
microenvironment in gastric cancer. Microbiome. 11:862023.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Yang J, Peng Y, Ding Y, Liu Y, Wang Y, Liu
Y and Liu C: The clinicopathological and molecular characteristics
of endocervical gastric-type adenocarcinoma and the use of
claudin18.2 as a potential therapeutic target. Mod Pathol.
37:1005692024. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Martinez-Ciarpaglini C, Barros R,
Caballero C, Boggino H, Alarcon-Molero L, Peleteiro B, Ruiz-García
E, Fernandez-Figueroa E, Herrera-Goepfert R, Díaz-Romero C, et al:
Comprehensive histopathological analysis of gastric cancer in
European and Latin America populations reveals differences in PDL1,
HER2, p53 and MUC6 expression. Gastric Cancer. 28:160–173. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Garcia E, Carvalho F, Amorim A and David
L: MUC6 gene polymorphism in healthy individuals and in gastric
cancer patients from northern Portugal. Cancer Epidemiol Biomarkers
Prev. 6:1071–1074. 1997.
|
|
90
|
Dashti F, Mirazimi SMA, Rabiei N, Fathazam
R, Rabiei N, Piroozmand H, Vosough M, Rahimian N, Hamblin MR and
Mirzaei H: The role of non-coding RNAs in chemotherapy for
gastrointestinal cancers. Mol Ther Nucleic Acids. 26:892–926. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Hashemipour M, Boroumand H, Mollazadeh S,
Tajiknia V, Nourollahzadeh Z, Rohani Borj M, Pourghadamyari H,
Rahimian N, Hamblin MR and Mirzaei H: Exosomal microRNAs and
exosomal long non-coding RNAs in gynecologic cancers. Gynecol
Oncol. 161:314–327. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Aghdam AM, Amiri A, Salarinia R,
Masoudifar A, Ghasemi F and Mirzaei H: MicroRNAs as diagnostic,
prognostic, and therapeutic biomarkers in prostate cancer. Crit Rev
Eukaryot Gene Expr. 29:127–139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Walsh MD, Clendenning M, Williamson E,
Pearson SA, Walters RJ, Nagler B, Packenas D, Win AK, Hopper JL,
Jenkins MA, et al: Expression of MUC2, MUC5AC, MUC5B, and MUC6
mucins in colorectal cancers and their association with the CpG
island methylator phenotype. Mod Pathol. 26:1642–1656. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Tanaka Y, Eizuka M, Uesugi N, Kawasaki K,
Yamano H, Suzuki H, Matsumoto T and Sugai T: Traditional serrated
adenoma has two distinct genetic pathways for molecular
tumorigenesis with potential neoplastic progression. J
Gastroenterol. 55:846–857. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Bartley AN, Thompson PA, Buckmeier JA,
Kepler CY, Hsu CH, Snyder MS, Lance P, Bhattacharyya A and Hamilton
SR: Expression of gastric pyloric mucin, MUC6, in colorectal
serrated polyps. Mod Pathol. 23:169–176. 2010. View Article : Google Scholar
|
|
96
|
Gibson JA, Hahn HP, Shahsafaei A and Odze
RD: MUC expression in hyperplastic and serrated colonic polyps:
Lack of specificity of MUC6. Am J Surg Pathol. 35:742–749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Owens SR, Chiosea SI and Kuan SF:
Selective expression of gastric mucin MUC6 in colonic sessile
serrated adenoma but not in hyperplastic polyp aids in
morphological diagnosis of serrated polyps. Mod Pathol. 21:660–669.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Ahn MH, Bae KB, Kwon JA, Choi HJ, Lee SR,
Kim SH, Jung TD, Kim SH, An MS, Hong KH, et al: Association of
MUC6-minisatellite variants with susceptibility to rectal
carcinoma. Mol Biol Rep. 40:303–308. 2013. View Article : Google Scholar
|
|
99
|
Abou-Alfa GK, Andersen JB, Chapman W,
Choti M, Forbes SJ, Gores GJ, Hong TS, Harding JJ, Vander Heiden
MG, Javle M, et al: Advances in cholangiocarcinoma research: Report
from the third Cholangiocarcinoma Foundation Annual Conference. J
Gastrointest Oncol. 7:819–827. 2016. View Article : Google Scholar
|
|
100
|
Thuwajit P, Chawengrattanachot W, Thuwajit
C, Sripa B, Paupairoj A and Chau-In S: Enhanced expression of mucin
6 glycoprotein in cholangiocarcinoma tissue from patients in
Thailand as a prognostic marker for survival. J Gastroenterol
Hepatol. 23:771–778. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Aishima S, Kuroda Y, Nishihara Y, Taguchi
K, Taketomi A, Maehara Y and Tsuneyoshi M: Gastric mucin phenotype
defines tumour progression and prognosis of intrahepatic
cholangiocarcinoma: gastric foveolar type is associated with
aggressive tumour behaviour. Histopathology. 49:35–44. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Park SY, Roh SJ, Kim YN, Kim SZ, Park HS,
Jang KY, Chung MJ, Kang MJ, Lee DG and Moon WS: Expression of MUC1,
MUC2, MUC5AC and MUC6 in cholangiocarcinoma: Prognostic impact.
Oncol Rep. 22:649–657. 2009.PubMed/NCBI
|
|
103
|
Albores-Saavedra J, Chable-Montero F,
Gonzalez-Romo MA, Ramirez Jaramillo M and Henson DE: Adenomas of
the gallbladder. Morphologic features, expression of gastric and
intestinal mucins, and incidence of high-grade dysplasia/carcinoma
in situ and invasive carcinoma. Hum Pathol. 43:1506–1513. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Nagata S, Ajioka Y, Nishikura K, Watanabe
G, Inoue T, Yamaguchi K, Watanabe H, Tanaka M and Tsuneyoshi M:
Co-expression of gastric and biliary phenotype in pyloric-gland
type adenoma of the gallbladder: Immunohistochemical analysis of
mucin profile and CD10. Oncol Rep. 17:721–729. 2007.PubMed/NCBI
|
|
105
|
Sasaki M, Yamato T, Nakanuma Y, Ho SB and
Kim YS: Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma,
dysplasia and non-dysplastic epithelia of the gallbladder. Pathol
Int. 49:38–44. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Sato K, Ito E, Masaki Y and Ogawa M: A
case report of gallbladder cancer and pancreas cystic neoplasm
associated with pancreaticobiliary maljunction. Int J Surg Case
Rep. 85:1061702021. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Carrasco C, Tittarelli A, Paillaleve N,
Pozo MD, Rojas-Sepulveda D, Barria O, Fluxá P, Hott M, Martin C,
Quezada C and Salazar-Onfray F: The evaluation of 17
gastrointestinal tumor markers reveals prognosis value for MUC6,
CK17, and CD10 in gallbladder-cancer patients. Diagnostics (Basel).
11:1532021. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Rawla P, Sunkara T and Gaduputi V:
Epidemiology of pancreatic cancer: Global trends, etiology and risk
factors. World J Oncol. 10:10–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Xu DF, Wang LS and Zhou JH: Long noncoding
RNA CASC2 suppresses pancreatic cancer cell growth and progression
by regulating the miR24/MUC6 axis. Int J Oncol. 56:494–507.
2020.PubMed/NCBI
|
|
111
|
Lahdaoui F, Delpu Y, Vincent A, Renaud F,
Messager M, Duchene B, Leteurtre E, Mariette C, Torrisani J,
Jonckheere N and Van Seuningen I: miR-219-1-3p is a negative
regulator of the mucin MUC4 expression and is a tumor suppressor in
pancreatic cancer. Oncogene. 34:780–788. 2015. View Article : Google Scholar
|
|
112
|
Mohr AM, Bailey JM, Lewallen ME, Liu X,
Radhakrishnan P, Yu F, Tapprich W and Hollingsworth MA: MUC1
regulates expression of multiple microRNAs involved in pancreatic
tumor progression, including the miR-200c/141 cluster. PLoS One.
8:e733062013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Basturk O, Khayyata S, Klimstra DS, Hruban
RH, Zamboni G, Coban I and Adsay NV: Preferential expression of
MUC6 in oncocytic and pancreatobiliary types of intraductal
papillary neoplasms highlights a pyloropancreatic pathway, distinct
from the intestinal pathway, in pancreatic carcinogenesis. Am J
Surg Pathol. 34:364–370. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Li XL, Eishi Y, Bai YQ, Sakai H, Akiyama
Y, Tani M, Takizawa T, Koike M and Yuasa Y: Expression of the
SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J
Oncol. 24:257–263. 2004.PubMed/NCBI
|
|
115
|
Sakai H, Jinawath A, Yamaoka S and Yuasa
Y: Upregulation of MUC6 mucin gene expression by NFkappaB and Sp
factors. Biochem Biophys Res Commun. 333:1254–1260. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Wang Z, Banerjee S, Li Y, Rahman KM, Zhang
Y and Sarkar FH: Down-regulation of notch-1 inhibits invasion by
inactivation of nuclear factor-kappaB, vascular endothelial growth
factor, and matrix metalloproteinase-9 in pancreatic cancer cells.
Cancer Res. 66:2778–2784. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Zhang Y, Banerjee S, Wang Z, Xu H, Zhang
L, Mohammad R, Aboukameel A, Adsay NV, Che M, Abbruzzese JL, et al:
Antitumor activity of epidermal growth factor receptor-related
protein is mediated by inactivation of ErbB receptors and nuclear
factor-kappaB in pancreatic cancer. Cancer Res. 66:1025–1032. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Lee CS, Sund NJ, Vatamaniuk MZ,
Matschinsky FM, Stoffers DA and Kaestner KH: Foxa2 controls Pdx1
gene expression in pancreatic beta-cells in vivo. Diabetes.
51:2546–2551. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Sierzega M, Mlynarski D, Tomaszewska R and
Kulig J: Semiquantitative immunohistochemistry for mucin (MUC1,
MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal
cell adenocarcinoma improves diagnostic and prognostic performance.
Histopathology. 69:582–591. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Jinfeng M, Kimura W, Hirai I, Sakurai F,
Moriya T and Mizutani M: Expression of MUC5AC and MUC6 in invasive
ductal carcinoma of the pancreas and relationship with prognosis.
Int J Gastrointest Cancer. 34:9–18. 2003. View Article : Google Scholar
|
|
121
|
Awaya H, Takeshima Y, Yamasaki M and Inai
K: Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical
adenomatous hyperplasia, bronchioloalveolar carcinoma,
adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar
carcinoma of the lung. Am J Clin Pathol. 121:644–653. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Pereira MB, Dias AJ, Reis CA and Schmitt
FC: Immunohistochemical study of the expression of MUC5AC and MUC6
in breast carcinomas and adjacent breast tissues. J Clin Pathol.
54:210–213. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Do SI, Kim K, Kim DH, Chae SW, Park YL,
Park CH and Sohn JH: Associations between the Expression of Mucins
(MUC1, MUC2, MUC5AC, and MUC6) and clinicopathologic parameters of
human breast ductal carcinomas. J Breast Cancer. 16:152–158. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Oral O, Unverdi H, Kumcu E, Turkbey D,
Dogan S and Hucumenoglu S: Associations between the expression of
mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic
parameters of human breast carcinomas. Indian J Pathol Microbiol.
63:551–558. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Rakha EA, Boyce RW, Abd El-Rehim D, Kurien
T, Green AR, Paish EC, Robertson JF and Ellis IO: Expression of
mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their
prognostic significance in human breast cancer. Mod Pathol.
18:1295–1304. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
de Bolos C, Guma M, Barranco C, Garrido M,
Kim YS and Real FX: MUC6 expression in breast tissues and cultured
cells: abnormal expression in tumors and regulation by steroid
hormones. Int J Cancer. 77:193–199. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Buyuk M, Ozluk Y, Bakkaloglu DV, Ozkan B,
Firat P and Yilmazbayhan D: Evaluation of MUC1, MUC2, MUC5AC, and
MUC6 expression differences in lung adenocarcinoma subtypes by
using a final immunoreactivity score (FIRS). Turk Patoloji Derg.
39:64–74. 2023.
|
|
128
|
Copin MC, Buisine MP, Leteurtre E,
Marquette CH, Porte H, Aubert JP, Gosselin B and Porchet N:
Mucinous bronchioloalveolar carcinomas display a specific pattern
of mucin gene expression among primary lung adenocarcinomas. Hum
Pathol. 32:274–281. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Hamamoto A, Abe Y, Nishi M, Fujimori S,
Ohnishi Y, Yamazaki H, Oida Y, Miyazaki N, Inada K, Ueyama Y, et
al: Aberrant expression of the gastric mucin MUC6 in human
pulmonary adenocarcinoma xenografts. Int J Oncol. 26:891–896.
2005.PubMed/NCBI
|
|
130
|
Kishikawa S, Hayashi T, Saito T, Takamochi
K, Kohsaka S, Sano K, Sasahara N, Sasa K, Kurihara T, Hara K, et
al: Diffuse expression of MUC6 defines a distinct
clinicopathological subset of pulmonary invasive mucinous
adenocarcinoma. Mod Pathol. 34:786–797. 2021. View Article : Google Scholar
|
|
131
|
Lee HK, Kwon MJ, Seo J, Kim JW, Hong M,
Park HR, Min SK, Choe JY, Ra YJ, Jang SH, et al: Expression of
mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer:
Comparison with EGFR-mutated lung cancer. Pathol Res Pract.
215:459–465. 2019. View Article : Google Scholar
|
|
132
|
Rerkpichaisuth V, Lau RP, Meyerson C and
Fishbein GA: The utility of the lineage specific
immunohistochemical stains SATB2, CDX2, and villin, and the mucin
glycoproteins MUC2, MUC5AC, and MUC6 to distinguish pulmonary
invasive mucinous adenocarcinoma from metastatic colorectal
carcinoma. Hum Pathol. 151:1056272024. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Nishiumi N, Abe Y, Inoue Y, Hatanaka H,
Inada K, Kijima H, Yamazaki H, Tatematsu M, Ueyama Y, Iwasaki M, et
al: Use of 11p15 mucins as prognostic factors in small
adenocarcinoma of the lung. Clin Cancer Res. 9:5616–5619.
2003.PubMed/NCBI
|
|
134
|
Rahimian N, Razavi ZS, Aslanbeigi F,
Mirkhabbaz AM, Piroozmand H, Shahrzad MK, Hamblin MR and Mirzaei H:
Non-coding RNAs related to angiogenesis in gynecological cancer.
Gynecol Oncol. 161:896–912. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Leroy X, Ballereau C, Villers A, Saint F,
Aubert S, Gosselin B, Porchet N and Copin MC: MUC6 is a marker of
seminal vesicle-ejaculatory duct epithelium and is useful for the
differential diagnosis with prostate adenocarcinoma. Am J Surg
Pathol. 27:519–521. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Kudryavtseva AV, Lukyanova EN, Kharitonov
SL, Nyushko KM, Krasheninnikov AA, Pudova EA, Guvatova ZG, Alekseev
BY, Kiseleva MV, Kaprin AD, et al: Bioinformatic identification of
differentially expressed genes associated with prognosis of locally
advanced lymph node-positive prostate cancer. J Bioinform Comput
Biol. 17:19500032019. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Schaid DJ, McDonnell SK, FitzGerald LM,
DeRycke L, Fogarty Z, Giles GG, MacInnis RJ, Southey MC,
Nguyen-Dumont T, Cancel-Tassin G, et al: Two-stage study of
familial prostate cancer by whole-exome sequencing and custom
capture identifies 10 novel genes associated with the risk of
prostate cancer. Eur Urol. 79:353–361. 2021. View Article : Google Scholar :
|
|
138
|
Sarvizadeh M, Hasanpour O, Naderi
Ghale-Noie Z, Mollazadeh S, Rezaei M, Pourghadamyari H, Masoud
Khooy M, Aschner M, Khan H, Rezaei N, et al: Allicin and digestive
system cancers: From chemical structure to its therapeutic
opportunities. Front Oncol. 11:6502562021. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Savardashtaki A, Shabaninejad Z,
Movahedpour A, Sahebnasagh R, Mirzaei H and Hamblin MR: miRNAs
derived from cancer-associated fibroblasts in colorectal cancer.
Epigenomics. 11:1627–1645. 2016. View Article : Google Scholar
|
|
140
|
Urick ME and Bell DW: Clinical
actionability of molecular targets in endometrial cancer. Nat Rev
Cancer. 19:510–521. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Razavi ZS, Tajiknia V, Majidi S, Ghandali
M, Mirzaei HR, Rahimian N, Hamblin MR and Mirzaei H: Gynecologic
cancers and non-coding RNAs: Epigenetic regulators with emerging
roles. Crit Rev Oncol Hematol. 157:1031922021. View Article : Google Scholar
|
|
142
|
Hodgson A, Parra-Herran C and Mirkovic J:
Immunohistochemical expression of HIK1083 and MUC6 in endometrial
carcinomas. Histopathology. 75:552–558. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Fulgione C, Raffone A, Travaglino A,
Arciuolo D, Santoro A, Cianfrini F, Russo D, Varricchio S, Raimondo
I, Inzani F, et al: Diagnostic accuracy of HIK1083 and MUC6 as
immunohistochemical markers of endocervical gastric-type
adenocarcinoma: A systematic review and meta-analysis. Pathol Res
Pract. 241:1542612023. View Article : Google Scholar
|
|
144
|
Alameda F, Mejias-Luque R, Garrido M and
de Bolos C: Mucin genes (MUC2, MUC4, MUC5AC, and MUC6) detection in
normal and pathological endometrial tissues. Int J Gynecol Pathol.
26:61–65. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Carbone FR and Gleeson PA: Carbohydrates
and antigen recognition by T cells. Glycobiology. 7:725–730. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Cloos PA and Christgau S:
Post-translational modifications of proteins: implications for
aging, antigen recognition, and autoimmunity. Biogerontology.
5:139–158. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Kontani K, Taguchi O, Narita T, Izawa M,
Hiraiwa N, Zenita K, Takeuchi T, Murai H, Miura S and Kannagi R:
Modulation of MUC1 mucin as an escape mechanism of breast cancer
cells from autologous cytotoxic T-lymphocytes. Br J Cancer.
84:1258–1264. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Hoshi H, Sawada T, Uchida M, Iijima H,
Kimura K, Hirakawa K and Wanibuchi H: MUC5AC protects pancreatic
cancer cells from TRAIL-induced death pathways. Int J Oncol.
42:887–893. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Thomas A and Giaccone G: Why has active
immunotherapy not worked in lung cancer? Ann Oncol. 26:2213–2220.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Xu X, Padilla MT, Li B, Wells A, Kato K,
Tellez C, Belinsky SA, Kim KC and Lin Y: MUC1 in macrophage:
Contributions to cigarette smoke-induced lung cancer. Cancer Res.
74:460–470. 2014. View Article : Google Scholar
|
|
151
|
Pelosi G and Sonzogni A: MUC6 distribution
in the spectrum of pulmonary mucinous adenocarcinoma. Mod Pathol.
35:2025–2026. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Hoshi H, Sawada T, Uchida M, Saito H,
Iijima H, Toda-Agetsuma M, Wada T, Yamazoe S, Tanaka H, Kimura K,
et al: Tumor-associated MUC5AC stimulates in vivo tumorigenicity of
human pancreatic cancer. Int J Oncol. 38:619–627. 2011.PubMed/NCBI
|
|
153
|
Slovin SF, Ragupathi G, Musselli C,
Olkiewicz K, Verbel D, Kuduk SD, Schwarz JB, Sames D, Danishefsky
S, Livingston PO and Scher HI: Fully synthetic carbohydrate-based
vaccines in biochemically relapsed prostate cancer: Clinical trial
results with alpha-N-acetylgalactosamine-O-serine/threonine
conjugate vaccine. J Clin Oncol. 21:4292–4298. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Kang S, Bae MJ, Kang MK, Kim H, Kang YR,
Jo WS, Lee CG, Jung B, Lee J, Moon C, et al: Possible association
of G6PC2 and MUC6 induced by low-dose-rate irradiation in mouse
intestine with inflammatory bowel disease. Mol Med Rep. 30:1272024.
View Article : Google Scholar
|
|
155
|
Cin M, Gundogar O, Yarikkaya E and Cin S:
The importance of MUC6 immunohistochemistry staining in the
histopathologic examination of Crohn's disease: Can we enhance our
diagnostic power? Ann Diagn Pathol. 78:1524822025. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Wong N, Beavers S, Gill P, Heryet A and
Linares J: Calponin and MUC6 complement inhibin as diagnostic
immunomarkers of serous cystadenoma in endoscopic ultrasound-guided
aspiration/biopsy specimens. Histopathology. 79:252–259. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Yamada S, Yamanoi K, Sato Y and Nakayama
J: Diffuse MIST1 expression and decreased alpha1,4-linked
N-acetylglucosamine (alphaGlcNAc) glycosylation on MUC6 are
distinct hallmarks for gastric neoplasms showing oxyntic gland
differentiation. Histopathology. 77:413–422. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Zhong F, Ren Z, Li W, Jones T, Zeng X,
Wang S, Tao X and Zhao C: The sensitivity and specificity of
Claudin18.2 and MUC6 in the differential diagnosis of endocervical
gastric-type glandular lesions. Hum Pathol. 160:1058372025.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Shi H, Zhang W, Hu B, Wang Y, Zhang Z, Sun
Y, Mao G, Li C and Lu S: Whole-exome sequencing identifies a set of
genes as markers of hepatocellular carcinoma early recurrence.
Hepatol Int. 17:393–405. 2023. View Article : Google Scholar
|
|
160
|
Kim GH, Lee JS, Lee JH and Park YS:
Oxyntic gland neoplasms - from adenoma to advanced gastric cancer:
A review of 29 cases. J Gastric Cancer. 24:378–390. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Kurosawa T, Murakami T, Yamashiro Y,
Terukina H, Hayashi T, Saito T, Nojiri S, Sakamoto K, Nagahara A
and Yao T: Mucin phenotypes and clinicopathological features of
colorectal adenocarcinomas: Correlation with colorectal
adenocarcinoma with enteroblastic differentiation. Pathol Res
Pract. 232:1538402022. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Tanabe H, Uehara T and Ota H: Cell
lineage-specific immunohistochemical markers in biliary
intraepithelial neoplasia: Implications for subclassification and
grading. Pathol Res Pract. 269:1558962025. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Riley NM, Wen RM, Bertozzi CR, Brooks JD
and Pitteri SJ: Measuring the multifaceted roles of mucin-domain
glycoproteins in cancer. Adv Cancer Res. 157:83–121. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Gupta R, Ponangi R and Indresh KG: Role of
glycosylation in breast cancer progression and metastasis:
Implications for miRNA, EMT and multidrug resistance. Glycobiology.
33:545–555. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Costa VD, Marino KV, Rodriguez-Zraquia SA,
Festari MF, Lores P, Costa M, Landeira M, Rabinovich GA, van Vliet
SJ and Freire T: Lung tumor cells with different Tn antigen
expression present distinctive immunomodulatory properties. Int J
Mol Sci. 23:120472022. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Iwaya M, Kodama M, Abe K, Maeda K,
Nakajima T, Uehara T, Nishio R, Yamana T, Riddell R, Ota H, et al:
Variability in morphology and immunohistochemistry of Crohn's
disease-associated small bowel neoplasms: Implications of Claudin
18 and Cadherin 17 expression for tumor-targeted immunotherapies.
Virchows Arch. 486:595–603. 2025. View Article : Google Scholar
|
|
167
|
Yang Y, Akashi Y, Shimomura O, Tateno H,
Saito S, Hiemori K, Miyazaki Y, Furuta T, Kitaguchi D, Kuroda Y, et
al: Glycan expression profile of signet ring cell gastric cancer
cells and potential applicability of rBC2LCN-targeted lectin drug
conjugate therapy. Gastric Cancer. 25:896–905. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Ideo H, Tsuchida A and Takada Y:
Lectin-based approaches to analyze the role of glycans and their
clinical application in disease. Int J Mol Sci. 25:102312024.
View Article : Google Scholar : PubMed/NCBI
|
